Package Leaflet: Information for the Patient
Brivaracetam Sandoz 25 mg film-coated tablets EFG
Brivaracetam Sandoz 50 mg film-coated tablets EFG
Brivaracetam Sandoz 75 mg film-coated tablets EFG
Brivaracetam Sandoz 100 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Keep this leaflet, you may need to read it again.
Contents of the pack
What is Brivaracetam Sandoz
Brivaracetam Sandoz contains the active substance brivaracetam. It belongs to a group of medicines called “antiepileptics”. These medicines are used to treat epilepsy.
What Brivaracetam Sandoz is used for
Do not take Brivaracetam Sandoz:
Warnings and precautions
Consult your doctor or pharmacist before starting to take brivaracetam:
Children
Brivaracetam is not recommended for use in children under 2 years of age.
Other medicines and Brivaracetam Sandoz
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
In particular, tell your doctor if you are taking any of the following medicines, as your doctor may need to adjust your dose of brivaracetam:
Taking Brivaracetam Sandoz with alcohol
Pregnancy and breastfeeding
Women of childbearing potential should discuss the use of contraceptives with their doctor.
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
It is not recommended to take brivaracetam if you are pregnant, as the effects of brivaracetam on pregnancy and the fetus are unknown.
It is not recommended to breastfeed your baby while taking brivaracetam, as brivaracetam is excreted in breast milk.
Do not stop treatment without consulting your doctor first. Stopping treatment could increase the number of seizures you have and harm your baby.
Driving and using machines
Brivaracetam Sandoz contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again. Other forms of this medicine may be more suitable for some patients, e.g. children (if they cannot swallow whole tablets, for example). Consult your doctor or pharmacist.
You will take brivaracetam together with other medicines to treat epilepsy.
How much to take
Your doctor will calculate the correct daily dose for you. Take the daily dose divided into two equal doses, approximately 12 hours apart.
Adolescents and children weighing 50 kg or more, and adults
Adolescents and children weighing between 20 kg and less than 50 kg
Children weighing between 10 kg and less than 20 kg
Patient with liver problems
If you have liver problems:
How to take Brivaracetam Sandoz tablets
Duration of treatment with Brivaracetam
Brivaracetam is a long-term treatment. Continue taking brivaracetam until your doctor tells you to stop.
If you take more Brivaracetam Sandoz than you should
If you take more brivaracetam than you should, consult your doctor. You may feel dizzy and drowsy. You may also experience some of the following symptoms: feeling unwell, feeling like you are spinning, balance problems, anxiety, feeling very tired, irritability, aggression, difficulty sleeping, depression, thoughts or attempts to harm yourself or suicide.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Brivaracetam
If you stop taking Brivaracetam
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common:may affect more than 1 in 10 people.
Common: may affect up to 1 in 10 people.
Uncommon: may affect up to 1 in 100 people
Frequency not known:frequency cannot be estimated from the available data
Other side effects in children
Common:may affect up to 1 in 10 people.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month shown.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Brivaracetam
Each Brivaracetam Sandoz 50 mg film-coated tablet contains 50 mg of brivaracetam.
Each Brivaracetam Sandoz 75 mg film-coated tablet contains 75 mg of brivaracetam.
Each Brivaracetam Sandoz 100 mg film-coated tablet contains 100 mg of brivaracetam.
The other ingredients are:
Brivaracetam Sandoz 25 mg tablets also contain: black iron oxide (E172) and yellow iron oxide (E172).
Brivaracetam Sandoz 50 mg tablets also contain: yellow iron oxide (E172).
Brivaracetam Sandoz 75 mg tablets also contain: black iron oxide (E172) and red iron oxide (E172).
Brivaracetam Sandoz 100 mg tablets also contain: yellow iron oxide (E172) and black iron oxide (E172).
Appearance and packaging
Brivaracetam Sandoz 25 mg tablets are film-coated, grey, oblong, biconvex and have “25” engraved on one side and are plain on the other.
Brivaracetam Sandoz 50 mg tablets are film-coated, yellow, oblong, biconvex and have “50” engraved on one side and are plain on the other.
Brivaracetam Sandoz 75 mg tablets are film-coated, purple, oblong, biconvex and have “75” engraved on one side and are plain on the other.
Brivaracetam Sandoz 100 mg tablets are film-coated, green, oblong, biconvex and have “100” engraved on one side and are plain on the other.
Brivaracetam Sandoz is marketed in packs with Aluminio-OPA/Al/PVC blisters of 14 or 56 film-coated tablets or in multiple packs containing 168 (3 packs of 56) film-coated tablets or in single-dose blisters of 14x1 or 56x1 film-coated tablets or in multiple packs containing 168 (3 packs of 56x1) film-coated tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble,
C/Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
PharOS MT Ltd.
HF62X, Hal Far Industrial Estate
Birzebbugia BBG3000
Malta
Or
PharOS Pharmaceutical Oriented Services Ltd.
Lesvou Street End, Thesi Loggos Industrial Zone
Metamorfossi, 14452
Greece
Or
Lek Pharmaceuticals d.d.
Verovškova ulica 57
1526 Ljubljana
Slovenia
This medicine is authorised in the Member States of the European Economic Area under the following names:
Hungary: Brivaracetam Sandoz 10mg filmtabletta
Brivaracetam Sandoz 25mg filmtabletta
Brivaracetam Sandoz 50mg filmtabletta
Brivaracetam Sandoz 75mg filmtabletta
Brivaracetam Sandoz 100mg filmtabletta
Czech Republic: Brivaracetam Sandoz
Germany: Brivaracetam - 1 A Pharma 10 mg Filmtabletten
Brivaracetam - 1 A Pharma 25 mg Filmtabletten
Brivaracetam - 1 A Pharma 50 mg Filmtabletten
Brivaracetam - 1 A Pharma 75 mg Filmtabletten
Brivaracetam - 1 A Pharma 100 mg Filmtabletten
Denmark: Brivaracetam Sandoz
Greece: Brivaracetam/Sandoz
Spain: Brivaracetam Sandoz 25 mg film-coated tablets EFG
Brivaracetam Sandoz 50 mg film-coated tablets EFG
Brivaracetam Sandoz 75 mg film-coated tablets EFG
Brivaracetam Sandoz 100 mg film-coated tablets EFG
Italy: Brivaracetam Sandoz
Netherlands: Brivaracetam Sandoz 25 mg, filmomhulde tabletten
Brivaracetam Sandoz 50 mg, filmomhulde tabletten
Brivaracetam Sandoz 75 mg, filmomhulde tabletten
Brivaracetam Sandoz 100 mg, filmomhulde tabletten
Date of last revision of this leaflet: February 2025
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/